MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Long-term course and confounding factors of MDS-UPDRS in a longitudinal single-center (DeNoPa) and a multicenter cohort (PPMI)

    M. Bartl, M. Dakna, S. Schade, E. Lang, C. Trenkwalder, B. Mollenhauer (Göttingen, Germany)

    Objective: To systematically compare long-term course of Parkinson's disease (PD) by the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and investigate possible predictive parameters of different…
  • MDS Virtual Congress 2020

    Developing A Novel Disease-Specific Psychosis Severity Scale in Parkinson’s disease (Psy-PD): A Pilot Study

    Y.M Wan, E.K Tan, D. Aarsland, T.S Lee, Y.L Lo, SKS. Ting, P. Martinez-Martin, K.R Chaudhuri (London, United Kingdom)

    Objective: To develop and assess the psychometrics of a disease-specific psychosis severity rating scale (Psy-PD) for a one-stop assessment of change in psychotic symptoms in…
  • MDS Virtual Congress 2020

    Evaluating patient out-of-pocket (OOP) expenses using real world utilization data of botulinum toxins

    L. Turner-Stokes, A. Lysandropoulos, S. Wietek, C. Divers (Harrow, United Kingdom)

    Objective: The objective of this study was to evaluate the impact of different brands of botulinum neurotoxin type A (BoNT-A) on OOP patient spending based…
  • MDS Virtual Congress 2020

    Retrospective review of MRI guided focused ultrasound thalamotomy referrals: experience from a single neuromodulation center

    L. Pan, M. Banvard, A. Mogilner, M. Pourfar (New York, NY, USA)

    Objective: To evaluate referrals, patient characteristics and decision outcomes for MRI guided focused ultrasound at a single neuromodulation center. Background: Transcranial MRI guided focused ultrasound…
  • MDS Virtual Congress 2020

    Deep brain stimulation in Parkinson’s disease: Selection criteria, post-surgery improvement and complications

    F. Aziouaz, T. Dellal, Y. Mebrouk (Oujda, Morocco)

    Objective: The objective of our study is to specify the selection criteria necessary to benefit from deep brain stimulation, to study clinical progress and improvement…
  • MDS Virtual Congress 2020

    Plasticity of frequency dependent tremor control in Parkinson disease (PD) subthalamic nucleus (STN) deep brain stimulation (DBS) implanted individuals

    E. Hargreaves, D. Schneider, R. DiPaola, J. Chen, S. Danish, D. Caputo (New Brunswick, NJ, USA)

    Objective: To document DBS induced frequency parameter neuroplasticity in STN DBS implanted individuals with tremor dominant PD. Background: We have noted the ability to reduce…
  • MDS Virtual Congress 2020

    The short- and long-term outcomes of STN DBS in PD patients with or without RBD

    S.M Park, R. Kim, J.H Shin, H.J Kim, B.S Jeon (Seoul, Republic of Korea)

    Objective: We aimed to assess the short- and long-term outcomes of bilateral subthalamic (STN) deep brain stimulation (DBS) including the motor performance and quality of…
  • MDS Virtual Congress 2020

    Correlation of Lead Location with Clinical Outcomes in a Double-Blinded Randomized Controlled Trial Evaluating Subthalamic Deep Brain Stimulation in Parkinson’s Disease (INTREPID)

    J. Vitek, R. Jain, R. Woon, L. Chen, P. Starr (Minneapolis, MN, USA)

    Objective: To assess the relationship between lead location in the subthalamic nucleus (STN) and deep brain stimulation (DBS) outcomes as reported in the INTREPID clinical…
  • MDS Virtual Congress 2020

    A New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson’s Disease

    N. Akram, H. Li, A. Ben-Joseph, C. Budu, D. Gallagher, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: 1. To develop a web-based test that objectively measures distal bradykinesia, 2. To validate the test by assessing PD patients and healthy controls, and…
  • MDS Virtual Congress 2020

    Real-World Evidence for a Smartwatch-based Parkinson’s Motor Assessment App in Patients Undergoing Therapy Changes

    A. Hadley, D. Riley, D. Heldman (Cleveland, OH, USA)

    Objective: We sought to investigate patient and clinician usability of a smartwatch-based wearable motor assessment system for measuring Parkinson’s disease (PD) motor symptoms in patients undergoing…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley